CD274 and lung carcinoma: In this study, PD-L1 expression in stage III cell lung cancer was not correlated with any of the standard clinicopathological features, including sex, Tumor, Node and Metastasis stage, smoking status, neoadjuvant chemotherapy, or patient age, nor with disease outcomes.